PortfoliosLab logoPortfoliosLab logo
CORT vs. FXI
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

CORT vs. FXI - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Corcept Therapeutics Incorporated (CORT) and iShares China Large-Cap ETF (FXI). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, CORT achieves a 138.25% return, which is significantly higher than FXI's -7.83% return. Over the past 10 years, CORT has outperformed FXI with an annualized return of 31.68%, while FXI has yielded a comparatively lower 3.13% annualized return.


CORT

1D
-0.41%
1M
45.25%
YTD
138.25%
6M
-5.77%
1Y
16.48%
3Y*
52.65%
5Y*
30.95%
10Y*
31.68%

FXI

1D
1.09%
1M
-7.76%
YTD
-7.83%
6M
-8.72%
1Y
-2.91%
3Y*
10.41%
5Y*
-3.08%
10Y*
3.13%
*Multi-year figures are annualized to reflect compound growth (CAGR)

CORT vs. FXI - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
CORT
Corcept Therapeutics Incorporated
138.25%-30.94%55.14%59.92%2.58%-24.31%116.20%-9.43%-26.02%148.76%
FXI
iShares China Large-Cap ETF
-7.83%28.95%28.98%-12.42%-20.66%-20.06%8.92%14.90%-13.28%36.26%

Correlation

The correlation between CORT and FXI is 0.22, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.22

Correlation (3Y)
Calculated over the trailing 3-year period

0.21

Correlation (5Y)
Calculated over the trailing 5-year period

0.22

Correlation (10Y)
Calculated over the trailing 10-year period

0.22

Correlation (All Time)
Calculated using the full available price history since Oct 8, 2004

0.19

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

CORT vs. FXI — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CORT
CORT Risk / Return Rank: 5353
Overall Rank
CORT Sharpe Ratio Rank: 5151
Sharpe Ratio Rank
CORT Sortino Ratio Rank: 5252
Sortino Ratio Rank
CORT Omega Ratio Rank: 6363
Omega Ratio Rank
CORT Calmar Ratio Rank: 4949
Calmar Ratio Rank
CORT Martin Ratio Rank: 4949
Martin Ratio Rank

FXI
FXI Risk / Return Rank: 88
Overall Rank
FXI Sharpe Ratio Rank: 88
Sharpe Ratio Rank
FXI Sortino Ratio Rank: 88
Sortino Ratio Rank
FXI Omega Ratio Rank: 88
Omega Ratio Rank
FXI Calmar Ratio Rank: 88
Calmar Ratio Rank
FXI Martin Ratio Rank: 88
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CORT vs. FXI - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Corcept Therapeutics Incorporated (CORT) and iShares China Large-Cap ETF (FXI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


CORTFXIDifference
Sharpe ratioReturn per unit of total volatility

+0.36

Sortino ratioReturn per unit of downside risk

+0.90

Omega ratioGain probability vs. loss probability

1.17

0.99

+0.18

Calmar ratioReturn relative to maximum drawdown

0.26

-0.18

+0.44

Martin ratioReturn relative to average drawdown

0.47

-0.38

+0.85

CORT vs. FXI - Sharpe Ratio Comparison

The current CORT Sharpe Ratio is 0.22, which is higher than the FXI Sharpe Ratio of -0.15. The chart below compares the historical Sharpe Ratios of CORT and FXI, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

CORT vs. FXI - Drawdown Comparison

The maximum CORT drawdown since its inception was -94.29%, which is greater than FXI's maximum drawdown of -72.68%. Use the drawdown chart below to compare losses from any high point for CORT and FXI.


Loading charts...

Drawdown Indicators


CORTFXIDifference

Max Drawdown

Largest peak-to-trough decline

-94.29%

-72.68%

-21.61%

Max Drawdown (1Y)

Largest decline over 1 year

-64.40%

-16.03%

-48.37%

Max Drawdown (3Y)

Largest decline over 3 years

-71.85%

-28.72%

-43.13%

Max Drawdown (5Y)

Largest decline over 5 years

-71.85%

-54.94%

-16.91%

Max Drawdown (10Y)

Largest decline over 10 years

-71.85%

-60.81%

-11.04%

Current Drawdown

Current decline from peak

-27.41%

-27.42%

+0.01%

Average Drawdown

Average peak-to-trough decline

-53.45%

-31.21%

-22.24%

Ulcer Index

Depth and duration of drawdowns from previous peaks

35.37%

7.66%

+27.71%

Volatility

CORT vs. FXI - Volatility Comparison

Corcept Therapeutics Incorporated (CORT) has a higher volatility of 14.28% compared to iShares China Large-Cap ETF (FXI) at 6.22%. This indicates that CORT's price experiences larger fluctuations and is considered to be riskier than FXI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


CORTFXIDifference

Volatility (1M)

Calculated over the trailing 1-month period

14.28%

6.22%

+8.06%

Volatility (6M)

Calculated over the trailing 6-month period

85.36%

14.30%

+71.06%

Volatility (1Y)

Calculated over the trailing 1-year period

76.98%

19.90%

+57.08%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

74.58%

31.67%

+42.91%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

67.23%

27.64%

+39.59%

Dividends

CORT vs. FXI - Dividend Comparison

CORT has not paid dividends to shareholders, while FXI's dividend yield for the trailing twelve months is around 2.62%.


PositionTTM20252024202320222021202020192018201720162015
CORT
Corcept Therapeutics Incorporated
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
FXI
iShares China Large-Cap ETF
2.62%2.42%1.76%3.17%2.61%1.60%2.19%2.74%2.69%2.31%2.69%2.90%

Frequently Asked Questions


CORT and FXI have a correlation of 0.22, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

CORT has higher volatility (14.28%) compared to FXI (6.22%). In terms of maximum drawdown, CORT dropped -94.29% vs FXI's -72.68%.

CORT currently has the higher Sharpe Ratio (0.21 vs -0.15), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for CORT and FXI

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer